The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Eldepryl 5 mg Tablets

Orion CorporationPA1327/003/001

Main Information

Trade NameEldepryl 5 mg Tablets
Active SubstancesSelegiline hydrochloride
Dosage FormTablet
Licence HolderOrion Corporation
Licence NumberPA1327/003/001

Group Information

ATC CodeN04BD Monoamine oxidase B inhibitors
N04BD01 selegiline


License statusAuthorised
Licence Issued03/01/1996
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back